Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2016 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

Rüdiger Sauer1 Lung Centre Ulm, Ulm, Germany

Michaela Hänsel2 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany

Roland Buhl3 Pulmonary Department, Mainz University Hospital, Mainz, Germany

Roman A Rubin4 Pulmonary Specialist Practice, Wiesbaden, Germany

Marcel Frey5 Biometrics, Alcedis GmbH, Gießen, Germany

Thomas Glaab2 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany;3 Pulmonary Department, Mainz University Hospital, Mainz, GermanyCorrespondence[email protected]

Pages 891-898 | Published online: 27 Apr 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BatemanEDTashkinDSiafakasNA one-year trial of tiotropium Respimat® plus usual therapy in COPD patientsRespir Med2010104101460147220620037
PubMed Web of Science ®Google Scholar
CooperCBCelliBRJardimJRTreadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trialChest2013144249049723558890
PubMed Web of Science ®Google Scholar
TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
PubMed Web of Science ®Google Scholar
VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
PubMed Web of Science ®Google Scholar
WiseRAAnzuetoACottonDTiotropium Respimat inhaler and the risk of death in COPDN Engl J Med2013369161491150123992515
PubMed Web of Science ®Google Scholar
YohannesAMWillgossTGVestboJTiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomesRespir Care201156447748721255503
PubMed Web of Science ®Google Scholar
DeeksEDOlodaterol: a review of its use in chronic obstructive pulmonary diseaseDrugs201575666567325773742
PubMed Web of Science ®Google Scholar
RoskellNSAnzuetoAHamiltonADisseBBeckerKOnce-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterolInt J Chron Obstruct Pulmon Dis2014981382425114521
PubMed Web of Science ®Google Scholar
Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [updated February 18, 2015] Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb18.pdfAccessed September 30, 2015
Google Scholar
ZuWallackRAllenLHernandezGTingNAbrahamsREfficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studiesInt J Chron Obstruct Pulmon Dis201491133114425342898
PubMed Web of Science ®Google Scholar
BuhlRMaltaisFAbrahamsRTiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)Eur Respir J201545496997925573406
PubMed Web of Science ®Google Scholar
SinghDFergusonGTBolitschekJTiotropium + olodaterol shows clinically meaningful improvements in quality of lifeRespir Med2015109101312131926320402
PubMed Web of Science ®Google Scholar
CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J200219221722411866001
PubMed Web of Science ®Google Scholar
VinckenWvan NoordJAGreefhorstAPMImproved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J200219220921611871363
PubMed Web of Science ®Google Scholar
Rau-BergerHMitfesselHGlaabTTiotropium Respimat® improves physical functioning in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2010536737321103403
PubMedGoogle Scholar
GlaabTVogelmeierCBuhlROutcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitationsRespir Res2010117920565728
PubMed Web of Science ®Google Scholar
BrazierJEHarperRJonesNMValidating the SF-36 health survey questionnaire: new outcome measure for primary careBMJ199230568461601641285753
PubMed Web of Science ®Google Scholar
WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923064734831593914
PubMed Web of Science ®Google Scholar
WareJEJrGandekBOverview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) ProjectJ Clin Epidemiol199851119039129817107
PubMed Web of Science ®Google Scholar
GummessonCAtroshiIEkdahlCPerformance of health-status scales when used selectively or within multi-scale questionnaireBMC Med Res Methodol20033312585967
PubMedGoogle Scholar
CohenJStatistical Power Analysis for the Behavioral Sciences2nd edHillsdale, NJLawrence Erlbaum Associates1988
Google Scholar
FergusonGTFležarMKornSEfficacy of tiotropium + olodaterol in patients with chronic obstructive pulmonary disease by initial disease severity and treatment intensity: a post hoc analysisAdv Ther201532652353626112656
PubMed Web of Science ®Google Scholar
Arp AdamsSMatthewsCEEbbelingCBThe effect of social desirability and social approval on self-reports of physical activityAm J Epidemiol2005161438939815692083
PubMed Web of Science ®Google Scholar
WelkGJKimYStanfillBValidity of 24-h physical activity recall: physical activity measurement surveyMed Sci Sports Exerc201446102014202424561818
PubMed Web of Science ®Google Scholar
HanadaSWadaSOhnoTSawaguchiHMurakiMTohdaYQuestionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchInt J Chron Obstruct Pulmon Dis201510697725609941
PubMed Web of Science ®Google Scholar
ConcatoJShahNHorwitzRIRandomized, controlled trials, observational studies, and the hierarchy of research designsN Engl J Med2000342251887189210861325
PubMed Web of Science ®Google Scholar
MichelMCGoepelMTreatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practiceEur Urol200038Suppl 1404711111207
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date